Omnicell, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Randall A. Lipps
- Full Time Employees
- 3,620
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 590 East Middlefield Road Mountain View CA United States of America 94043
- IPO Date
- Aug 9, 2001
- CIK
- 0000926326
- Website
- omnicell.com
- Similar Companies
- Business
- Omnicell, Inc. is a healthcare technology company specializing in medication management solutions and adherence tools designed to enhance healthcare delivery and operational efficiency. The company offers an extensive portfolio that includes automated medication dispensing systems; pharmacy automation equipment; medication adherence packaging; analytics and inventory management software; point-of-care pharmacy automation; adherence packaging systems under the MyMD packaging brand; and clinical decision support applications. Omnicell serves healthcare providers, pharmacies, hospitals, and long-term care facilities across the United States, Canada, and select international markets. Founded in 1992, the company is headquartered in Mountain View, California. In the past 1-2 years, Omnicell has focused on expanding its clinical and financial analytics capabilities, integrating new software enhancements to improve medication safety and operational workflows. The company has also been active in strategic partnerships that broaden its technology ecosystem and has launched updated versions of its adherence packaging solutions. Omnicell continues to extend its presence in the pharmacy automation market through selective acquisitions and innovation in medication management systems. These initiatives reflect a strategic shift toward comprehensive service offerings that combine hardware, software, and analytics to support a data-driven approach in healthcare operations. Omnicell operates primarily in the healthcare technology and medical devices industry, targeting hospital systems, health systems, retail pharmacies, and senior care providers. Its product and service offerings are designed to address challenges in medication adherence, reduce medication errors, optimize pharmacy workflows, and improve patient outcomes. The company maintains a broad geographic footprint across North America with growing influence internationally, supported by its network of subsidiaries and partners specializing in healthcare technology solutions.
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Omnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?
Omnicell, Inc. (OMCL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Omnicell: Why I'm Long Into Q2 Earnings Despite The Bookings Wobble
Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business
Top Robotics Stocks Worth Investing in the Second Half of 2026
Wall Street Analysts Predict a 40.57% Upside in Omnicell (OMCL): Here's What You Should Know
Omnicell (OMCL) is a Top-Ranked Momentum Stock: Should You Buy?
A Look at Omnicell Inc (OMCL) After 4.1% Gain -- GF Value $38.65 vs Price $43.62
Is Omnicell Stock a Smart Addition to Your Portfolio Now?
Omnicell (OMCL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
Omnicell (OMCL) Up 0.1% Since Last Earnings Report: Can It Continue?
Omnicell Stock Surges 57.3% in a Year: What's Driving It?
Should You Buy Omnicell (OMCL) After Golden Cross?
How Much Upside is Left in Omnicell (OMCL)? Wall Street Analysts Think 39.87%
Omnicell, Inc. (OMCL) Shareholder/Analyst Call Prepared Remarks Transcript
Omnicell, Inc. (OMCL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Here's Why Omnicell (OMCL) is a Strong Momentum Stock
Omnicell (OMCL) is a Great Momentum Stock: Should You Buy?